Refine
Document Type
- Article (3)
Language
- English (3)
Has Fulltext
- yes (3)
Keywords
- Membrane Technology (2)
- AGMD (1)
- Brine Recovery (1)
- Distillation (1)
- Electrodialysis (1)
- Elektrodialyse (1)
- Energy Demand (1)
- Lithium (1)
- Lithium-Ion Batteries (1)
- Lithium-Ionen-Akkumulator (1)
The production of pharmaceutical ingredients, intermediates and final products strongly depends on the utilization of water. Water is also required for the purification and preparation of reagents. Each specific application determines the respective water quality. In the European Union, the European Pharmacopeia (Ph. Eur.) contains the official standards that assure quality control of pharmaceutical products during their life cycle. According to this, the production of water for pharmaceutical use is mainly based on multi-stage distillation and membrane processes, especially, reverse osmosis. Membrane distillation (MD) could be an alternative process to these classical methods. It offers advantages in terms of energy demand and a compact apparatus design. In the following study, the preparation of pharmaceutical-grade water from tap water in a one-step process using MD is presented. Special emphasis is placed on the performance of two different module designs and on the selection of optimum process parameters.
The importance of lithium as a raw material is steadily increasing, especially in the growing markets of grid energy and e-mobility. Today, brines are the most important lithium sources. The rising lithium demand raises concerns over the expandability and the environmental impact of common mining techniques, which are mainly based on the evaporation of brine solutions (Salars) in arid and semiarid areas. In this case, much of the water contained in the brine is lost. Purification processes lead to further water losses of the ecosystems. This calls for new and improved processes for lithium production; one of them is electrodialysis (ED). Electrodialysis offers great potential in accessing lithium from brines in a more environmentally friendly way; furthermore, for the recovery of lithium from spent lithium-ion batteries (LIB), electrodialysis may become a vital technology. The following study focused on investigating the effect of varying brine compositions, different ED operation modes, and limiting factors on the use of ED for concentrating lithium-containing brine solutions. Synthetic lithium salt solutions (LiCl, LiOH) were concentrated using conventional ED in batch-wise operation. While the diluate solution was exchanged once a defined minimum concentration was reached, the concentrate solution was concentrated to the respective maximum. The experiments were conducted using a lab-scale ED-plant (BED1-3 from PCCell GmbH, Germany). The ion-exchange membranes used were PCSK and PCSA. The treated solutions varied in concentration and composition. Parameters such as current density, current efficiency, and energy requirements were evaluated. ED proved highly effective in the concentration of lithium salt solutions. Lithium chloride solutions were concentrated up to approximately 18-fold of the initial concentration. Current efficiencies and current densities depended on voltage, concentration, and the composition of the brine. Overall, the current efficiencies reached maximum values of around 70%. Furthermore, the experiments revealed a water transport of about 0.05 to 0.075% per gram of LiCl transferred from the diluate solution to the concentrate solution.
Water serves for the production of pharmaceutical ingredients, intermediates and final products. Accordingly, the quality requirements are particularly high. Next to quality, sustainability of the production and climate change mitigation will play an increasingly important role. For instance, in 2015, the total global emissions of the pharma sector was significantly higher than the CO<sub>2</sub> emissions generated by the automotive sector. Thus, efforts must be made at all stages of production of pharmaceuticals to reduce the environmental impact.